Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New Stem-Free shoulder implant shows promise in european study

NCT ID NCT01700543

First seen Jan 05, 2026 · Last updated Jun 20, 2026 · Updated 23 times

Summary

This study followed 152 people who received the Sidus Stem-Free Shoulder implant for severe shoulder pain and disability due to arthritis or other joint diseases. The implant is designed to replace the shoulder joint without a long stem, potentially preserving more bone. Researchers measured pain, function, quality of life, and implant survival to confirm the device's safety and performance.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OSTEOARTHRITIS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • AKH Linz

    Linz, Austria

  • Azienda Ospedaliera Universitaria Careggi

    Florence, Italy

  • Centre Hospitalier Universitaire Toulouse

    Toulouse, France

  • Charité

    Berlin, Germany

  • Gemeinschaftspraxis am Wall

    Rinteln, Germany

  • Groupe Chirurgical Thiers

    Grenoble, France

  • New Royal Infirmary of Edinburgh

    Edinburgh, United Kingdom

  • Orthopaedische Chirurgie Muenchen

    Munich, Germany

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Sidus Stem-Free Shoulder implant (a shoulder replacement device)

What this could lead to

If successful, this implant could provide a reliable option for shoulder replacement with less bone removal, potentially improving recovery and implant longevity.

What could go wrong

This is a post-market study, meaning the device is already on the market. It is not approved in the US, and results may not apply to all patients. Risks include implant failure, infection, or need for revision surgery.

Conditions

The condition(s) this trial relates to.

arthritic joint disease osteoarthritis osteonecrosis rheumatoid arthritis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.